Home » Topics » Regulatory » Patents

Patents
RSS

Novo Nordisk describes heterocyclic compounds for neurogenic pain/inflammation

May 8, 1997

Pharmacia & Upjohn prepares new antibacterial agents

May 8, 1997

ECE inhibitors from Santen

May 8, 1997

Warner-Lambert reveals agents with dual dopaminergic/serotonergic activity

May 7, 1997

nAChR ligands prepared by Novo Nordisk

May 7, 1997

N-Oxide oxazolidinones from Pharmacia & Upjohn

May 7, 1997

Novel semisynthetic macrolide immunosuppressants disclosed by Abbott

May 7, 1997

Kyowa Hakko claims analgesic agents

May 7, 1997

Potent and selective ETA antagonists from Shionogi

May 7, 1997

Analgesics reported by Daiichi and Fuji

May 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...